NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
Ovarian cancer is the 3rd most common cancer among women with gynecological neoplasms in Russia, at the same time, it have the highest mortality rate among malignant tumors of the female reproductive system. Because ofvague clinical picture and the lack of effective methods for early detection and s...
Main Authors: | A. E. Solopova, A. A. Chashchin, A. G. Solopova, S. N. Gurov, A. D. Makatsariya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2016-09-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/293 |
Similar Items
-
EPITHELIAL OVARIAN CANCER. CLINICAL LECTURE
by: A. E. Solopova, et al.
Published: (2016-10-01) -
AEG-1 as a predictor of sensitivity to neoadjuvant chemotherapy in advanced epithelial ovarian cancer
by: Wang Y, et al.
Published: (2016-04-01) -
Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
by: Kazuto Nakamura, et al.
Published: (2020-08-01) -
Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study
by: Yan Gao, et al.
Published: (2019-09-01) -
Role of Lymphadenectomy During Interval Debulking Surgery Performed After Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
by: Minjun He, et al.
Published: (2021-03-01)